Answers are grounded in this paper and cite their sources.
Early in 1937 Schwentker, Gelman and Long 1 described the use of sulfanilamide in the treatment of 10 patients with meningococcic meningitis at Sydenham Hospital. Nine of the 10 patients treated recovered. Many other reports confirming the value of this drug in meningococcic meningitis have appeared. 2 It soon became apparent that sulfanilamide was at least as effective in meningitis as antimeningococcus serum. In fact, all the evidence points to the conclusion that the drug is more reliable than serum. For example, in Waghelstein's 3 series reported from Sydenham Hospital in 1938 the mortality rate in a series of 368 serum treated patients was 27 per cent, while among 72 patients receiving sulfanilamide the fatality rate was 15 per cent. As each new sulfonamide drug became available it was employed in meningococcic infections. During the past two years it has become evident that sulfapyridine, 4 sulfathiazole 5 and sulfadiazine 6
No takes yet. Share an insight, caveat, or question.
Horace L. Hodes (1942) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: